Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole

被引:53
作者
Oakley, KL
Moore, CB
Denning, DW
机构
[1] N Manchester Gen Hosp, Dept Infect Dis & Trop Med, Manchester M8 6RB, Lancs, England
[2] Hope Hosp, Dept Med, Salford M6 8HD, Lancs, England
[3] Hope Hosp, Dept Microbiol, Salford M6 8HD, Lancs, England
[4] Univ Manchester, Manchester M8 6RB, Lancs, England
关键词
D O I
10.1128/AAC.43.5.1264
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We compared the in vitro activity of liposomal nystatin (Nyotran) with those of other antifungal agents against 60 Aspergillus isolates. Twelve isolates were itraconazole resistant. For all isolates, geometric mean (GM) MICs (micrograms per milliliter) were 2.30 for liposomal nystatin, 0.58 for itraconazole, 0.86 for amphotericin B (AB) deoxycholate, 9.51 for nystatin, 2.07 for liposomal AB, 2.57 for AB lipid complex, and 0.86 for AB colloidal dispersion. Aspergillus terreus (GM, 8.72 mu g/ml; range, 8 to 16 mu g/ml) was significantly less susceptible to all of the polyene drugs than all other species (P = 0.0001).
引用
收藏
页码:1264 / 1266
页数:3
相关论文
共 15 条
[1]   Evidence of multiple extracellular phospholipase activities of Aspergillus fumigatus [J].
Birch, M ;
Robson, G ;
Law, D ;
Denning, DW .
INFECTION AND IMMUNITY, 1996, 64 (03) :751-755
[2]   INVASIVE ASPERGILLOSIS IN IMMUNOCOMPROMISED PATIENTS [J].
DENNING, DW .
CURRENT OPINION IN INFECTIOUS DISEASES, 1994, 7 (04) :456-462
[3]  
DENNING DW, 1995, ANN MED INTERNE, V146, P106
[4]   OVERVIEW OF LIPOSOMES [J].
GREGORIADIS, G .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 :39-48
[5]  
Hay R J, 1994, J Infect, V28 Suppl 1, P35, DOI 10.1016/S0163-4453(94)95956-0
[6]  
HAZEN EL, 1951, P SOC EXP BIOL MED, V76, P93, DOI 10.3181/00379727-76-18397
[7]   Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations [J].
Johnson, EM ;
Ojwang, JO ;
Szekely, A ;
Wallace, TL ;
Warnock, DW .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (06) :1412-1416
[8]   Liposomal amphotericin B (AmBisome) reduces dissemination of infection as compared with amphotericin B deoxycholate (Fungizone) in a rat model of pulmonary aspergillosis [J].
Leenders, ACAP ;
deMarie, S ;
tenKate, MT ;
BakkerWoudenberg, IAJM ;
Verbrugh, HA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 (02) :215-225
[9]   FORMULATION, TOXICITY, AND ANTIFUNGAL ACTIVITY INVITRO OF LIPOSOME-ENCAPSULATED NYSTATIN AS THERAPEUTIC AGENT FOR SYSTEMIC CANDIDIASIS [J].
MEHTA, RT ;
HOPFER, RL ;
GUNNER, LA ;
JULIANO, RL ;
LOPEZBERESTEIN, G .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (12) :1897-1900
[10]   NON-CANDIDA FUNGAL-INFECTIONS AFTER BONE-MARROW TRANSPLANTATION - RISK-FACTORS AND OUTCOME [J].
MORRISON, VA ;
HAAKE, RJ ;
WEISDORF, DJ .
AMERICAN JOURNAL OF MEDICINE, 1994, 96 (06) :497-503